BB Biotech AG
Investment company focused on public biotechnology firms developing novel drugs.
BION | SW
Overview
Corporate Details
- ISIN(s):
- CH0027659793 (+1 more)
- LEI:
- 391200MBZQNPFHIVKO34
- Country:
- Switzerland
- Address:
- Schwertstrasse 6, 8200 Schaffhausen
Description
BB Biotech AG is an investment company specializing in the fast-growing biotechnology market. With over 30 years of experience, it is one of the world's largest investors in this sector. The company's investment strategy focuses on a portfolio of publicly listed companies that are developing and commercializing novel drugs. These target companies are selected for their potential to create significant value for the healthcare system by addressing unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-08 01:00 |
EQS-News: BB BIOTECH AG: Forza d’intervento rapido molecolare per il sistema im…
|
Italian | 15.5 KB | ||
| 2022-12-08 01:00 |
EQS-News: BB BIOTECH AG: Molecular strike force for the immune system
|
English | 13.1 KB | ||
| 2022-12-08 01:00 |
EQS-News: BB BIOTECH AG: Molekulare Eingreiftruppen für das Immunsystem
|
German | 14.5 KB | ||
| 2022-10-21 07:00 |
BB Biotech AG publishes its interim report
|
English | 6.6 KB | ||
| 2022-10-21 02:00 |
EQS-News: BB BIOTECH AG: La legislazione statunitense sui prezzi dei farmaci sp…
|
Italian | 24.5 KB | ||
| 2022-10-21 02:00 |
EQS-News: BB BIOTECH AG: US drug pricing legislation drives biotech business to…
|
English | 21.8 KB | ||
| 2022-10-21 02:00 |
EQS-News: BB BIOTECH AG: Biotech Industrie mit weiteren Innovationen als Antwor…
|
German | 24.4 KB | ||
| 2022-10-21 02:00 |
EQS-Adhoc: BB Biotech AG pubblica il proprio rapporto intermedio
|
Italian | 5.2 KB | ||
| 2022-10-21 02:00 |
EQS-Adhoc: BB Biotech AG publishes its interim report
|
English | 4.8 KB | ||
| 2022-10-21 02:00 |
EQS-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht
|
German | 5.0 KB | ||
| 2022-10-21 00:00 |
Q3 statement / Q3 financial report 2022
|
English | 3.0 MB | ||
| 2022-09-14 08:30 |
Edison issues review on BB Biotech (BION)
|
English | 10.0 KB | ||
| 2022-08-30 11:00 |
BB BIOTECH AG: Moderna was just the beginning
|
English | 12.8 KB | ||
| 2022-08-30 02:00 |
DGAP-News: BB BIOTECH AG: Moderna è stata solo l’inizio
|
Italian | 11.5 KB | ||
| 2022-08-30 02:00 |
DGAP-News: BB BIOTECH AG: Moderna was just the beginning
|
English | 10.6 KB |
Automate Your Workflow. Get a real-time feed of all BB Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BB Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BB Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-05 | N/A | Non-Executive member | Buy | None | 40,893.80 CHF |
| 2024-09-16 | N/A | Non-Executive member | Buy | None | 47,103.20 CHF |
| 2024-07-29 | N/A | Non-Executive member | Buy | None | 54,913.50 CHF |
| 2024-04-30 | N/A | Non-Executive member | Buy | None | 41,450.00 CHF |
| 2024-03-25 | N/A | Non-Executive member | Buy | None | 55,167.50 CHF |
| 2024-03-22 | N/A | Non-Executive member | Buy | None | 105,927.16 CHF |
Peer Companies
